Notice

As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.  

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at https://www.opm.gov/.

Call for Applications – Clinical Assay Development Program

The NCI Clinical Assay Development Program (CADP) is requesting project applications from investigators seeking clinical assay validation resources.  These resources are designed to assist with the development of assays that may predict therapy response or prognostic behavior of a diagnosed cancer, primarily for use in clinical trials. Approved projects for the NCI CADP will be provided access to the Institute’s assay development and validation resources, including project management support.

When applying to the CADP, it is important that investigators define the intended clinical use for the assay for which support is requested.  Assays submitted for CADP development services should have been tested on human tissue. As part of the application, investigators are required to provide basic assay protocol(s). Proposals will be reviewed for scientific merit, feasibility and clinical importance.

Application deadline: October 15, 2012.

To learn more about CADP or to submit an application, go to http://cadp.cancer.gov.

Please note this call for application is not a solicitation for biomarker discovery and is not a grants program.